RIO DE JANEIRO, BRAZIL - The National Health Surveillance Agency (ANVISA) approved on Tuesday, December 3rd, the release of the sale in pharmacies of cannabis-based products for medicinal use in Brazil.
The regulation was approved unanimously and is temporary, valid for three years.
In the same meeting of the body's board of directors, the cultivation of marijuana for medicinal purposes in Brazil was rejected, by 3 votes to 1.
With the decision, manufacturers wishing to enter the market will need to import the plant extract.
Regarding the sale in pharmacies, the norm becomes valid 90 days after its publication . . .